Table 3.
Treatment and Clinical Outcome of Data from Patients with Behçet’s Disease with Superior Mesenteric Artery Vasculitis.
No | References | Treatment | Outcome |
---|---|---|---|
1 | 12 | Prednisolone | NR |
2 | 13 | Prednisolone Laparotomy |
Symptoms worsened with prednisolone monotherapy, and continued laparotomy was successfully performed. |
3 | 14 | NR | NR |
4 | 15 | Prednisolone and antiplatelet agents | Corticosteroid and antiplatelet treatment was successful. |
5 | 16 | Laparotomy | Laparotomy was successfully performed. 3 year after surgical intervention, the preserved parts of the SMA were radiologically normal. |
6 | 17 | Laparotomy Prednisolone and antiplatelet agents |
Laparotomy was successfully performed, and corticosteroid and antiplatelet were prescribed. The patient was in good health at 1 year follow up. |
7 | 18 | Prednisolone | Prednisolone treatment was successfully performed. |
8 | 19 | TCAE | Endovascular treatment was successfully performed. |
9 | 20 | Bypass surgery | The bypass graft between the SMA and right iliac artery was successfully performed. After 2 years, the aneurysm of intracranial internal carotid artery was diagnosed and endovascular embolization was successfully performed. |
10 | 21 | Bypass surgery | The aneurysm of SMA was resection and bypass surgery through left radial artery was successful. After 4 years, the size of aneurysm of thoracic and abdominal increased, and stent graft treatment was successfully performed. |
11 | 22 | NR | NR |
12 | 23 | Laparotomy Prednisolone |
Laparotomy was performed successfully, and corticosteroid was prescribed. The patient was in good health at six months follow up. |
13 | 24 | Laparotomy and anti-inflammatory medications (Prednisolone, Tripterygium wilfordii and thalidomide) | The patient was in good health at eight months follow up. |
14 | 25 | Laparotomy | Laparotomy was successfully performed. |
15 | 26 | NR | NR |
NR: not reported, TCAE: transcatheter arterial embolization, SMA: superior mesenteric artery